PROM1 is an inclusion criterion in 1 clinical trial for acute leukemia, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and acute leukemia as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for breast carcinoma, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and breast carcinoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for colorectal carcinoma, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and colorectal carcinoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for hepatocellular carcinoma, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and hepatocellular carcinoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for malignant brain neoplasm, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and malignant brain neoplasm as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for malignant glioma, of which 1 is open and 0 are closed. Of the trial that contains PROM1 status and malignant glioma as inclusion criteria, 1 is phase 1 (1 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for ovarian carcinoma, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and ovarian carcinoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].

PROM1 is an inclusion criterion in 1 clinical trial for pancreatic carcinoma, of which 0 are open and 1 is closed. Of the trial that contains PROM1 status and pancreatic carcinoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) [4].